Article info
PDFEditorial
Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?
- Correspondence to Professor Floris P J G Lafeber, UMC Utrecht, Rheumatology & Clinical Immunology, Utrecht 3508 GA, The Netherlands; f.lafeber{at}umcutrecht.nlFPJGL and JMvL contributed equally.
Citation
Strontium ranelate: ready for clinical use as disease-modifying osteoarthritis drug?
Publication history
- Received October 5, 2012
- Revised November 8, 2012
- Accepted November 15, 2012
- First published January 4, 2013.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions